MIT has launched an as-yet unnamed spinout to develop a smart drug-delivery pill to help plan more effective treatment regimens for patients.
Massachusetts Institute of Technology (MIT) has launched an as-yet unnamed US-based spinout to commercialise a 3D-printable drug-delivery pill that would enable doctors to more effectively administer medication dosages, R&D Magazine has reported.
The ingestible technology would remain in the patient’s stomach for almost a month, relying on its built-in sensors and wireless Bluetooth transmitters to help professionals judge when medication should be dispersed.
MIT hopes the pill will prevent patients with diseases including HIV and malaria from prematurely stopping their regimens, while also stopping potential overdoses of addictive painkillers such as opioids.
The capsule contains a star-shaped device with six minuscule retractable arms, each of which includes four small, fillable compartments where drugs and sensors are loaded up for treatment. It dissolves once swallowed so that the device can anchor in the stomach by expanding its arms.
Doctors and patients would receive medical information from the…
